Metropolitan Life Insurance Co NY trimmed its stake in Ball Co. (NYSE:BLL) by 4.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 46,166 shares of the industrial products company’s stock after selling 2,355 shares during the period. Metropolitan Life Insurance Co NY’s holdings in Ball were worth $2,671,000 as of its most recent SEC filing.
Several other large investors also recently bought and sold shares of the company. Global Retirement Partners LLC increased its stake in shares of Ball by 281.1% in the 4th quarter. Global Retirement Partners LLC now owns 644 shares of the industrial products company’s stock worth $30,000 after acquiring an additional 475 shares in the last quarter. Massey Quick Simon & CO. LLC bought a new position in shares of Ball in the 1st quarter worth about $30,000. Pearl River Capital LLC bought a new position in shares of Ball in the 1st quarter worth about $30,000. Oregon Public Employees Retirement Fund increased its stake in shares of Ball by 4,406.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,720,250 shares of the industrial products company’s stock worth $37,000 after acquiring an additional 1,682,073 shares in the last quarter. Finally, YorkBridge Wealth Partners LLC bought a new position in shares of Ball in the 1st quarter worth about $56,000. 82.13% of the stock is owned by hedge funds and other institutional investors.
Shares of BLL stock traded down $1.15 during trading hours on Friday, reaching $70.00. The company had a trading volume of 1,601,758 shares, compared to its average volume of 2,361,471. The business has a fifty day moving average of $66.51. Ball Co. has a one year low of $37.24 and a one year high of $72.34. The firm has a market capitalization of $23.82 billion, a price-to-earnings ratio of 31.82, a PEG ratio of 4.95 and a beta of 0.81. The company has a current ratio of 1.09, a quick ratio of 0.77 and a debt-to-equity ratio of 1.84.
The business also recently declared a quarterly dividend, which was paid on Monday, June 17th. Stockholders of record on Monday, June 3rd were paid a $0.15 dividend. The ex-dividend date was Friday, May 31st. This is a positive change from Ball’s previous quarterly dividend of $0.10. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.86%. Ball’s payout ratio is currently 27.27%.
In related news, Chairman John A. Hayes sold 9,111 shares of the firm’s stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $61.66, for a total value of $561,784.26. Following the transaction, the chairman now owns 472,141 shares of the company’s stock, valued at $29,112,214.06. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Scott C. Morrison sold 2,897 shares of Ball stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $63.06, for a total transaction of $182,684.82. Following the transaction, the vice president now directly owns 441,271 shares in the company, valued at approximately $27,826,549.26. The disclosure for this sale can be found here. In the last three months, insiders sold 42,078 shares of company stock worth $2,746,288. 1.80% of the stock is currently owned by insiders.
Several research analysts recently issued reports on BLL shares. Vertical Research lowered shares of Ball from a “hold” rating to a “sell” rating in a research note on Monday, July 8th. Zacks Investment Research lowered shares of GENEL ENERGY PL/ADR from a “buy” rating to a “hold” rating in a research note on Tuesday, May 7th. Citigroup raised their price objective on shares of Silgan from $34.00 to $36.00 and gave the company a “buy” rating in a research note on Thursday. BMO Capital Markets restated a “hold” rating on shares of Snc-Lavalin Group in a research note on Monday, April 8th. Finally, Wells Fargo & Co set a $9.00 price objective on shares of Bausch Health Companies and gave the company a “sell” rating in a research note on Friday, May 17th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have assigned a buy rating to the company. Ball presently has a consensus rating of “Hold” and an average target price of $58.01.
Ball Company Profile
Ball Corp. provides metal packaging for beverages, foods and household products, and of aerospace and other technologies and services to commercial and governmental customers. It operates through the following business segments: Beverage Packaging, North and Central America; Beverage Packaging, South America; Beverage Packaging, Europe; Food and Aerosol Packaging; and Aerospace.
Recommended Story: What is a Roth IRA?
Receive News & Ratings for Ball Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ball and related companies with MarketBeat.com's FREE daily email newsletter.